Global Circulating Tumor Cell Market Research Report - Forecast to 2023

Circulating Tumor Cell Market Research Report 2023

Circulating tumor cells (CTCs) are cancer cells that are separated from the solid tumor and enter the bloodstream. Circulating tumor cells can be used as a blood biomarker for the early diagnosis of carcinogenesis and cancer and help to monitor metastatic breast, colorectal, and prostate cancers.

The growth of the circulating tumor cells market can be driven by the growing prevalence of cancer, rising research and development in the biotechnology and pharmaceutical industry, and rising geriatric population. The growing prevalence of cancer is driving the growth of the market, as circulating tumor cells find their applications in the diagnosis of cancer and precision management. For instance, the National Center for Biotechnology Information (NCBI) stated that the projected cases of prostate cancer all over India for the year 2015 were 28,079. Furthermore, the Leukemia & Lymphoma Society estimated that around, 60,300 people are expected to be diagnosed with leukemia in 2018. The significant growth in the population of cancer patients is paving a way for the growth of the circulating tumor cells market.

The global circulating tumor cells market was valued USD 9393.1 million in 2017 and is expected to register a CAGR of 20.32% % over the forecast period.

Similarly, according to the National Health and Medical Research Council, the Australian government spent over USD 174.6 million on cancer research and development. This growing research and development in the field of healthcare are leading to the growth of the circulating tumor cells market.

Market Segmentation

The global circulating tumor cells market is segmented based on application, technology, and end-user.
Based on application, the market is further segmented into clinical, research, and drug development.
Based on technology, the market is segmented into CTC enrichment, CTC detection, and combined enrichment and separation of CTC (CTC analysis).
Based on end-user, the market is segmented into hospitals and clinics, research and academic institutes, and diagnostic centers.

Key Players

Greiner Bio-One International GmbH, Ikonisys Inc., Thermo Fisher Scientific, SRI International, STEMCELL Technologies, Miltenyi Biotec, Menarini Silicon Biosystems, QIAGEN Hannover (QIAGEN), F. Hoffmann-La Roche Ltd, NanoString Technologies, Inc., Fluxion Biosciences, Inc., and GE Healthcare, among others.

Study objectives

To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global circulating tumor cells market.
• To provide insights into factors influencing and affecting the market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global circulating tumor cells market
• To provide a detailed analysis of the value chain and supply chain of the global circulating tumor cells market

Target Audience

• Pharmaceutical and Biotechnology Companies
• Medical Devices Companies
• Research and Development (R&D) Institutes
• Market Research and Consulting Service Providers
• Potential Investors

Key Findings

• The global circulating tumor cells market is expected to reach USD 28,399.2million by 2023 at a CAGR of 20.32% from 2018 to 2023.
• On the basis of application, the clinical segment accounted for the major market share of 63% and was valued at USD 5,920.9 million in 2017.
• On the basis of technology, the CTC enrichment accounted for a major market share of 58.5% in 2017.
• The Americas holds the largest share of the global circulating tumor cells market which is expected to reach USD 13,011.5 million by 2023.
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 20.84% from 2018 to 2023.

Regional Analysis

Americas
o North America
US
Canada
o South America

Europe
o Western Europe
Germany
UK
France
Italy
Spain
Rest of Western Europe
o Eastern Europe

Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific

Middle East & Africa
o Middle East
o Africa

1 Report Prologue
2 Market Introduction
2.1 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising occurrence of cancer
4.2.2 Increasing research and development
4.2.3 Rising geriatric population
4.3 Restraint
4.3.1 High cost of CTC tests and instruments
4.4 Opportunity
4.4.1 Entering developing economies
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
5.2 Porter’s Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
6 Global Circulating Tumor Cell Market, by Application
6.1 Introduction
6.2 Clinical
6.3 Research
6.4 Drug Development
7 Global Circulating Tumor Cell Market, by Technology
7.1 Introduction
7.2 CTC Enrichment
7.3 CTC Detection
7.4 Combined Enrichment and Separation of CTC (CTC analysis)
8 Global Circulating Tumor Cell Market, by End-User
8.1 Introduction
8.2 Hospital & Clinics
8.3 Research & Academic Institutes
8.4 Diagnostic Centers
9 Global Circulating Tumor Cell Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 U.K
9.3.1.3 France
9.3.1.4 Spain
9.3.1.5 Italy
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
10 Competitive Landscape
10.1 Introduction
11 Company Profiles
11.1 Greiner Bio-One International GmbH
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products Offering
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.1.6 Key Strategy
11.2 Ikonisys Inc.
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products Offering
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategy
11.3 Thermo Fisher Scientific
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products Offering
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.3.6 Key Strategy
11.4 SRI International
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products Offering
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.4.6 Key Strategy
11.5 STEMCELL Technologies
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products Offering
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.5.6 Key Strategy
11.6 Miltenyi Biotec
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products Offering
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategy
11.7 Menarini Silicon Biosystems
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products Offering
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7.6 Key Strategy
11.8 QIAGEN Hannover (QIAGEN)
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products Offering
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.8.6 Key Strategy
11.9 F. Hoffmann-La Roche Ltd
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products Offering
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategy
11.1 NanoString Technologies, Inc.
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products Offering
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategy
11.11 Fluxion Biosciences, Inc.
11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Products Offering
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.11.6 Key Strategy
11.12 GE Healthcare
11.12.1 Company Overview
11.12.2 Financial Overview
11.12.3 Products Offering
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.12.6 Key Strategy
12 Appendix
12.1 Discussion Blue Print


List Of Tables

TABLE 1 GLOBAL CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 2 GLOBAL CIRCULATING TUMOR CELL MARKET FOR CLINICAL APPLICATION 2015-2023 (USD MILLION)
TABLE 3 GLOBAL CIRCULATING TUMOR CELL MARKET FOR RESEARCH APPLICATION 2015-2023 (USD MILLION)
TABLE 4 GLOBAL CIRCULATING TUMOR CELL MARKET FOR DRUG DEVELOPMENT APPLICATION 2015-2023 (USD MILLION)
TABLE 5 GLOBAL CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 6 GLOBAL CIRCULATING TUMOR CELL MARKET FOR CTC ENRICHMENT 2015-2023 (USD MILLION)
TABLE 7 GLOBAL CIRCULATING TUMOR CELL MARKET FOR CTC DETECTION 2015-2023 (USD MILLION)
TABLE 8 GLOBAL CIRCULATING TUMOR CELL MARKET FOR COMBINED ENRICHMENT AND SEPARATION OF CTC (CTC ANALYSIS) 2015-2023 (USD MILLION)
TABLE 9 GLOBAL CIRCULATING TUMOR CELL MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 10 GLOBAL CIRCULATING TUMOR CELL MARKET FOR HOSPITAL & CLINICS 2015-2023 (USD MILLION)
TABLE 11 GLOBAL CIRCULATING TUMOR CELL MARKET FOR RESEARCH & ACADEMIC INSTITUTES 2015-2023 (USD MILLION)
TABLE 12 GLOBAL CIRCULATING TUMOR CELL MARKET FOR DIAGNOSTIC CENTERS 2015-2023 (USD MILLION)
TABLE 13 GLOBAL CIRCULATING TUMOR CELL MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 14 AMERICAS CIRCULATING TUMOR CELL MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 15 AMERICAS CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 16 AMERICAS CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 17 AMERICAS CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 18 AMERICAS CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 19 AMERICAS CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 20 NORTH AMERICA CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 21 NORTH AMERICA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 22 NORTH AMERICA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 23 NORTH AMERICA CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 24 NORTH AMERICA CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 25 U.S CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 26 U.S CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 27 U.S CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 28 U.S CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 29 U.S CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 30 CANADA CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 31 CANADA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 32 CANADA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 33 CANADA CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 34 CANADA CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 35 SOUTH AMERICA CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 36 SOUTH AMERICA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 37 SOUTH AMERICA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 38 SOUTH AMERICA CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 39 SOUTH AMERICA CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 40 EUROPE CIRCULATING TUMOR CELL MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 41 EUROPE CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 42 EUROPE CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 43 EUROPE CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 44 EUROPE CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 45 EUROPE CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 46 WESTERN EUROPE CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 47 WESTERN EUROPE CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 48 WESTERN EUROPE CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 49 WESTERN EUROPE CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 50 WESTERN EUROPE CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 51 GERMANY CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 52 GERMANY CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 53 GERMANY CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 54 GERMANY CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 55 GERMANY CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 56 U.K CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 57 U.K CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 58 U.K CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 59 U.K CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 60 U.K CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 61 FRANCE CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 62 FRANCE CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 63 FRANCE CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 64 FRANCE CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 65 FRANCE CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 66 SPAIN CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 67 SPAIN CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 68 SPAIN CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 69 SPAIN CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 70 SPAIN CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 71 ITALY CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 72 ITALY CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 73 ITALY CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 74 ITALY CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 75 ITALY CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 76 REST OF WESTERN EUROPE CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 77 REST OF WESTERN EUROPE CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 78 REST OF WESTERN EUROPE CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 79 REST OF WESTERN EUROPE CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 80 REST OF WESTERN EUROPE CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 81 EASTERN EUROPE CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 82 EASTERN EUROPE CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 83 EASTERN EUROPE CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 84 EASTERN EUROPE CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 85 EASTERN EUROPE CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 86 ASIA PACIFIC CIRCULATING TUMOR CELL MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 87 ASIA PACIFIC CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 88 ASIA PACIFIC CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 89 ASIA PACIFIC CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 90 ASIA PACIFIC CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 91 ASIA PACIFIC CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 92 CHINA CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 93 CHINA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 94 CHINA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 95 CHINA CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 96 CHINA CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 97 JAPAN CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 98 JAPAN CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 99 JAPAN CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 100 JAPAN CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 101 JAPAN CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 102 INDIA CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 103 INDIA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 104 INDIA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 105 INDIA CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 106 INDIA CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 107 AUSTRALIA CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 108 AUSTRALIA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 109 AUSTRALIA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 110 AUSTRALIA CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 111 AUSTRALIA CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 112 REPUBLIC OF KOREA CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 113 REPUBLIC OF KOREA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 114 REPUBLIC OF KOREA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 115 REPUBLIC OF KOREA CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 116 REPUBLIC OF KOREA CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 117 REST OF ASIA PACIFIC CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 118 REST OF ASIA PACIFIC CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 119 REST OF ASIA PACIFIC CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 120 REST OF ASIA PACIFIC CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 121 REST OF ASIA PACIFIC CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 123 MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 124 MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 125 MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 126 MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 127 MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 128 MIDDLE EAST CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 129 MIDDLE EAST CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 130 MIDDLE EAST CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 131 MIDDLE EAST CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 132 MIDDLE EAST CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 133 AFRICA CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2015-2023 (USD MILLION)
TABLE 134 AFRICA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY TYPE 2015-2023 (USD MILLION)
TABLE 135 AFRICA CIRCULATING TUMOR CELL MARKET, FOR CLINICAL APPLICATION BY DIAGNOSIS & MANAGEMENT OF TUMOR MALIGNANCIES TYPE 2015-2023 (USD MILLION)
TABLE 136 AFRICA CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2015-2023 (USD MILLION)
TABLE 137 AFRICA CIRCULATING TUMOR CELL MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 138 TOP MANUFACTURERS IN THE GLOBAL CIRCULATING TUMOR CELLS MARKET 2017


List Of Figures

FIGURE 1 MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS
FIGURE 3 DRO ANALYSIS OF GLOBAL CIRCULATING TUMOR CELL MARKET
FIGURE 4 VALUE CHAIN: GLOBAL CIRCULATING TUMOR CELL MARKET
FIGURE 5 PORTER’S FIVE FORCES MODEL: GLOBAL CIRCULATING TUMOR CELL MARKET
FIGURE 6 GLOBAL CIRCULATING TUMOR CELL MARKET, BY APPLICATION 2017 & 2023 (USD MILLION)
FIGURE 7 GLOBAL CIRCULATING TUMOR CELL MARKET, BY TECHNOLOGY 2017 & 2023 (USD MILLION)
FIGURE 8 GLOBAL CIRCULATING TUMOR CELL MARKET, BY END-USER 2017 & 2023 (USD MILLION)
FIGURE 9 GLOBAL CIRCULATING TUMOR CELL MARKET SHARE, BY REGION 2017 (%)
FIGURE 10 AMERICAS CIRCULATING TUMOR CELL MARKET SHARE, BY REGION 2017 (%)
FIGURE 11 EUROPE CIRCULATING TUMOR CELL MARKET SHARE, BY REGION 2017 (%)
FIGURE 12 ASIA PACIFIC CIRCULATING TUMOR CELL MARKET SHARE, BY REGION 2017 (%)
FIGURE 13 MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SHARE, BY REGION 2017 (%)


Global Wound Care Management Devices Market

IntroductionGlobally the number of wound care patients have been increasing in recent years. The growth is mainly influenced in areas where the old age population is high, people are suffering

USD 3850 View Report

Global Wireless Healthcare Market

The Global Wireless Healthcare Market was valued at US$ XX Mn in 2016 and is expected to reach US$ XX Mn by 2022 growing at a CAGR of XX% during

USD 3850 View Report

Global and Southeast Asia Circulating Tumor Cells (CTCs) Detectors Industry, 2018 Market Research Report

The Global and Southeast Asia Circulating Tumor Cells (CTCs) Detectors Industry, 2013-2023 Market Research Report is a professional and in-depth study on the current state of the global Circulating Tumor

USD 3000 View Report

Global and Southeast Asia Circulating Tumor Cells (CTCs) Detector Industry, 2018 Market Research Report

The Global and Southeast Asia Circulating Tumor Cells (CTCs) Detector Industry, 2013-2023 Market Research Report is a professional and in-depth study on the current state of the global Circulating Tumor

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available